Genetics, Growing and Cultivation, Publicly Traded Companies

#279: Nick Sosiak, Cannara Biotech

Cannabinoid Connect 279: Nick Sosiak, Cannara Biotech

Nick Sosiak is the CFO of Cannara Biotech, a vertically integrated producer for the Québec and Canadian markets.

Topics Discussed:

  • The current state of the second wave of Canadian LPs
  • Shifting focus from cultivation to CPG
  • Product formulation trends in Canada
  • Canadian cannabis marketing restrictions
  • Genetics to keep SKUs fresh and maintain sales volume

Listen to the full episode

Watch on YouTube

This Episode is Sponsored By Regrow

Back to list

Related Posts